April 5, 2017
Radiopharmaceuticals market could double up in 4 years
According to the report, the global market radiopharmaceuticals were valued at nearly $5.1 billion and $5.7 billion in 2014 and 2015, respectively.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Avid Radiopharmaceuticals
October 7, 2015
Lilly Joins the Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) Study
Eli Lilly and Company and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, have announced financial commitment and continued scientific partnership to support the recently established Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) Study.